Piers John Morgan founded uniQure NV. Presently, Mr. Morgan is Chief Financial Officer of Compass Pathways Plc.
He is also on the board of Pharnext SA, Pathway Biotech Ltd. and Ikarovec Ltd. and Member of Institute of Chartered Accountants in England & Wales and Vice Chairman-Innovation & Funding Models at European Biopharmaceutical Enterprises.
In the past Mr. Morgan was Non-Executive Chairman at Trino Therapeutics Ltd., Chief Executive Officer & Director at C4X Discovery Holdings Plc and Chief Executive Officer & Director at C4X Discovery Ltd. (a subsidiary of C4X Discovery Holdings Plc), Chief Financial Officer of Onxeo SA, Chief Financial Officer at Verona Pharma Plc, Chief Financial Officer of uniQure NV and Chief Financial Officer & Vice President at Amsterdam Molecular Therapeutics (AMT) Holding NV (a subsidiary of uniQure NV), Principal at Close Brothers Group Plc, Chief Financial Officer of Phytopharm Plc and Chief Financial Officer at Arrow Therapeutics Ltd.
Mr. Morgan received a graduate degree from the University of Cambridge.